Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Gabapentin enacarbil；XP-13512 | C16H27NO6 | 478296-72-9 | Details |
| Galantide | C104H151N25O26S | 138579-66-5 | Details |
| FX-11 | C22H22O4 | 213971-34-7 | Details |
| Rapamycin | C51H79NO13 | 53123-88-9 | Details |
| GDC-0339 | C20H22F3N7OS | 1428569-85-0 | Details |
| Fmoc-PEG6-NHS ester | C34H44N2O12 | 1818294-31-3 | Details |
| Glesatinib；MGCD265 | C31H27F2N5O3S2 | 936694-12-1 | Details |
| Doxepin hydrochloride | C19H22ClNO | 1229-29-4 | Details |
| Valganciclovir hydrochloride | C14H23ClN6O5 | 175865-59-5 | Details |
| GNE-4997 | C25H27F2N5O3S | 1705602-02-3 | Details |
| FT827 | C27H28N6O5S | 1959537-86-0 | Details |
| GNE-781 | C27H33F2N7O2 | 1936422-33-1 | Details |
| FzM1.8 | C18H14N2O4 | 2204290-85-5 | Details |
| Gemcitabine elaidate；CO-101;Gemcitabine (elaidate);CP-4126;Gemcitabine 5'-elaidate | C27H43F2N3O5 | 210829-30-4 | Details |
| GNF179 | C22H23ClFN5O | 1261114-01-5 | Details |
| Foscarbidopa；Carbidopa 4′-monophosphate | C10H15N2O7P | 1907685-81-7 | Details |
| Fmoc-PEG4-Ala-Ala-Asn-PAB | C43H56N6O12 | 2055048-57-0 | Details |
| Fumonisin B1 | C34H59NO15 | 116355-83-0 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| Glibornuride | C18H26N2O4S | 26944-48-9 | Details |
| Fumonisin B2 | C34H59NO14 | 116355-84-1 | Details |
| Gisadenafil | C23H33N7O5S | 334826-98-1 | Details |
| Gadoxetate Disodium | C23H28GdN3NaO11- | 135326-22-6 | Details |
| Ipatasertib dihydrochloride；RG-7440 dihydrochloride;GDC-0068 dihydrochloride | C24H33Cl2N5O2 | 1396257-94-5 | Details |
| Fosravuconazole；BMS-379224;E-1224 | C23H20F2N5O5PS | 351227-64-0 | Details |
| FW1256 | C12H10NOPS | 117089-08-4 | Details |
| GNE-0723；GNE 0723 | C16H8ClF6N5OS | 1883518-31-7 | Details |
| FTBMT | C19H16F4N4O | 1358575-02-6 | Details |
| Glufosinate ammonium | C5H18N3O4P | 77182-82-2 | Details |
| gamma-DGG；γDGG;γ-D-Glutamylglycine | C7H12N2O5 | 6729-55-1 | Details |
| Fraxidin | C11H10O5 | 525-21-3 | Details |
| G-1 | C21H18BrNO3 | 881639-98-1 | Details |
| GNF351 | C24H25N7 | 1227634-69-6 | Details |
| GPR120 Agonist 3；GPR120-IN-1 | C19H23ClF3NO3 | 1599477-75-4 | Details |
| FR-188582 | C16H13ClN2O2S | 189699-82-9 | Details |
| GR 159897 | C23H27FN2O2S | 158848-32-9 | Details |
| GB1107 | C20H16Cl2F3N3O4S | 1978336-61-6 | Details |
| GPNA hydrochloride | C11H14ClN3O5 | 67953-08-6 | Details |
| Foropafant | C28H40N4S | 136468-36-5 | Details |
| Forodesine | C11H14N4O4 | 209799-67-7 | Details |
| Furobufen | C16H12O4 | 38873-55-1 | Details |
| Glyceryl monocaprate；Monocaprin;2,3-Dihydroxypropyl decanoate;DECANOIN | C13H26O4 | 26402-22-2 | Details |
| Fructosyl-lysine；Fructoselysine | C12H24N2O7 | 21291-40-7 | Details |
| Gidazepam；Gidasepam;Hydazepam;Hidazepam | C17H15BrN4O2 | 129186-29-4 | Details |
| GPP78；CAY10618 | C27H29N5O | 1202580-59-3 | Details |
| Inavolisib | C18H19F2N5O4 | 2060571-02-8 | Details |
| GLP-1R Antagonist 1 | C16H11ClF6N4O2 | 488097-06-9 | Details |
| GNE-6468 | C23H16ClN3O4 | 1677668-27-7 | Details |
| FR-190809 | C29H34FN3O6S2 | 215589-63-2 | Details |
| Iloperidone | C24H27FN2O4 | 133454-47-4 | Details |
| FTY720 (S)-Phosphate；(S)-FTY720 phosphate;(S)-FTY720P | C19H34NO5P | 402616-26-6 | Details |
| Sodium 4-phenylbutyrate | C10H13NaO2 | 1716-12-7 | Details |
| GI 181771 | C34H31N5O6 | 305366-98-7 | Details |
| Promestriene | C22H32O2 | 39219-28-8 | Details |
| GMBS | C12H12N2O6 | 80307-12-6 | Details |
| Gardiquimod | C17H23N5O | 1020412-43-4 | Details |
| GR148672X | C15H11F3N2O2S | 263890-70-6 | Details |
| Funapide；XEN402;TV 45070 | C22H14F3NO5 | 1259933-16-8 | Details |
| GNE-955 | C22H24N8O | 1527523-39-2 | Details |
| Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | C60H66N6O11 | 2055042-69-6 | Details |
| GNE-207 | C29H30N6O3 | 2158266-58-9 | Details |
| GNE-371 | C24H25N5O3 | 1926986-36-8 | Details |
| GANT 58 | C24H16N4S | 64048-12-0 | Details |
| GGsTop；Nahlsgen | C13H18NO7P | 926281-37-0 | Details |
| FTI-2153 | C25H30N4O3S | 344900-92-1 | Details |
| Glucagon (1-29), bovine, human, porcine；Porcine glucagon;Glucagon | C153H225N43O49S | 16941-32-5 | Details |
| Fmoc-PEG3-C2-NHS ester | C28H32N2O9 | 1352827-47-4 | Details |
| Fosdagrocorat；PF-04171327 | C29H30F3N2O5P | 1044535-58-1 | Details |
| G-744 | C29H29N5O3S | 1346669-54-2 | Details |
| Gboxin | C22H33ClN2O2 | 2101315-36-8 | Details |
| GS-6201 | C21H21F3N6O2 | 752222-83-6 | Details |
| Ravoxertinib hydrochloride；GDC-0994 (hydrochloride) | C21H19Cl2FN6O2 | 2070009-58-2 | Details |
| Glycerol phenylbutyrate | C33H38O6 | 611168-24-2 | Details |
| Fmoc-PEG4-NHS ester | C30H36N2O10 | 1314378-14-7 | Details |
| GNE-618 | C21H15F3N4O3S | 1362151-42-5 | Details |
| Gly-PEG3-amine | C12H27N3O4 | 2110448-97-8 | Details |
| GNE-049 | C27H32F2N6O2 | 1936421-41-8 | Details |
| FN-1501 | C22H25N9O | 1429515-59-2 | Details |
| Fumitremorgin C | C22H25N3O3 | 118974-02-0 | Details |
| GS-626510 | C25H22N4O | 1637770-13-8 | Details |
| Glisoxepide | C20H27N5O5S | 25046-79-1 | Details |
| Glufosfamide | C10H21Cl2N2O7P | 132682-98-5 | Details |
| Minocromil；FPL59360 | C18H16N2O6 | 85118-44-1 | Details |
| Fosteabine；Cytarabine ocfosfate;YNK 01 | C27H50N3O8P | 73532-83-9 | Details |
| Glucagon (1-29), bovine, human, porcine hydrochloride | 28270-04-4 | Details |
| Griseoluteic acid | C15H12N2O4 | 489-76-9 | Details |
| GN44028 | C18H15N3O2 | 1421448-26-1 | Details |
| GR 113808 | C19H27N3O4S | 144625-51-4 | Details |
| Drospirenone | C24H30O3 | 67392-87-4 | Details |
| Framycetin；Neomycin B;Fradiomycin B | C23H46N6O13 | 119-04-0 | Details |
| Glufosinate | C5H12NO4P | 51276-47-2 | Details |
| Glesatinib hydrochloride；MGCD265 hydrochloride | C31H28ClF2N5O3S2 | 1123838-51-6 | Details |
| Fonadelpar；NPS-005;SJP-0035 | C25H23F3N2O4S | 515138-06-4 | Details |
| Fmoc-PEG5-NHS ester | C32H40N2O11 | 1402080-11-8 | Details |
| GNE-272 | C22H25FN6O2 | 1936428-93-1 | Details |
| GLPG0974 | C25H25ClN2O4S | 1391076-61-1 | Details |
| GNE 5729 | C17H10Cl2F3N5O | 2026635-66-3 | Details |
| FR167344 free base | C30H28BrCl2N5O4 | 215258-13-2 | Details |
| Fosnetupitant；Pronetupitant | C31H35F6N4O5P | 1703748-89-3 | Details |
| Darifenacin hydrobromide | C28H31BrN2O2 | 133099-07-7 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | ||||